Collection 期刊論文 [105/106] 圖書 [0/1] 會議論文/會議摘要 [22/23] Siblings 何英剛(2006-2011) [38/38] 劉誠珍 [35/35] 周文海 [11/11] 林克明(2004-2009) [66/69] 林彥鋒 [28/29] 王先逸(2005-2010) [5/5] 王昀 [59/59] 王聲昌 [55/58] 羅爾維(2004-2012) [39/39] 謝奉勳 [32/34] 陳嘉祥(2009-2013) [62/64] 陳娟瑜(2004-2010) [89/92] 陳慧諴 [48/50] 陳為堅 [46/47] 陶寶綠 [34/36] 魏榮泰(2004-2010) [2/2] 其他 [152/155] 廖定烈(2005-2008) [18/18] 林兆東(2006-2009) [8/8] Community Statistics 近3年內發表的文件:23(17.69%) 含全文筆數:127(97.69%) 文件下載次數統計 下載大於0次:127(100.00%) 下載大於100次:116(91.34%) 檔案下載總次數:53445(1.00%) 最後更新時間: 2024-11-28 13:45 Top Upload Loading... Top Download Loading... Recent Submissions Association of bone turnover marker... Plasma leptin levels are lower in f... Metabolic activity of CYP2C19 and C... Ketamine-dependent patients with pe... Metabolic activity of CYP2C19 and C... Psychometric evaluation of the Chin... Multi-ancestry genome-wide associat... Classifying Alzheimer's disease and... Meta-analysis of CYP2C19 and CYP2D6... Biomarkers as potential indicators ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 101-125 of 130. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page

Date	Title	Relation
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2012-03	Genome-wide association study of treatment refractory schizophrenia in Han Chinese	PLoS ONE. 2012 Mar;7(3):Article number e33598.
2011-12	Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia	Journal of Clinical Psychopharmacology. 2011 Dec;31(6):758-762.
2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	Pharmacogenomics. 2011 Oct;12(10):1397-1406.
2011-08	CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer	Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
2011-06	ANXA7, PPP3CB, DNAJC9, and ZMYND17 Genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function	Biological Psychiatry. 2011 Jul;70(1):51-58.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	CACNG2 is associated with delusion-hallucination symptom dimension of schizophrenia, but not with clozapine treatment outcome	Biological Psychiatry. 2011 May;69(9 Suppl. 1):281S.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
2011-04	ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment	Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
2010-11	CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine	Pharmacogenomics. 2010 Nov;11(11):1535-1543.
2010-07	Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients	Biomedical Chromatography. 2010 Jul;24(7):782-788.
2010-05	Good responders have higher plasma concentrations of aripiprazole in patients with schizophrenia	International Journal of Neuropsychopharmacology. 2010 May;13(Suppl. S1):204.
2010-04	Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response	Pharmacogenomics. 2010 Apr;11(4):537-546.
2010-01-14	Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan	Neuroscience Letters. 2010 Jan 14;468(3):330-333.
2009-11	Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p	Genes, Brain and Behavior. 2009 Nov;8(8):785-794.
2009-10	Cytochrome P-450 Isozyme 2C19 Genetic Polymorphisms are Associated with Plasma Concentrations of Escitalopram	Therapeutic Drug Monitoring. 2009 Oct;31(5):166.
2009-07	Construction of Balanced Translocation t(1;11)(q42.1;q14.3) Probe and Screening Application in Genomic Samples in Taiwan	Journal of the Formosan Medical Association. 2009 Jul;108(7):587-591.
2009-04	Association of the 3'region of COMT with Schizophrenia in Taiwan	Journal of the Formosan Medical Association. 2009 Apr;108(4):301-309.
2008-12-12	A protein interaction based model for schizophrenia study	BMC Bioinformatics. 2008 Dec 12;9(Suppl. 12):Article number S23.
2008-11	RASD2, MYH9, and CACNG2 Genes at Chromosome 22q12 Associated with the Subgroup of Schizophrenia with Non-Deficit in Sustained Attention and Executive Function	Biological Psychiatry. 2008 Nov;64(9):789-796.
2007-12	HTF9C gene of 22q11.21 region associates with schizophrenia having deficit-sustained attention	Psychiatric Genetics. 2007 Dec;17(6):333-338.
2007-10	More evidence supports the association of PPP3CC with schizophrenia	Molecular Psychiatry. 2007 Oct;12(10):966-974.

Showing items 101-125 of 130. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page